Sökresultat

Obesity is a common cause of diabetes, heart disease and early death, but risk differs greatly from one person to the next. In work led by researchers at Lund University in Sweden as part of the Innovative Medicine Initiative project SOPHIA, a pioneering clinical risk prediction algorithm has been developed that splits obesity into 5 separate diagnostic profiles each with contrasting health conseq

https://www.ludc.lu.se/article/new-precision-medicine-approach-helps-detect-subgroups-people-obesity-high-risk-diabetes-and-heart - 2025-12-13

Simon Boas, who wrote a candid account of living with cancer, passed away on July 15 at the age of 47. In a recent BBC interview, the former aid worker told the reporter: “My pain is under control and I’m terribly happy – it sounds weird to say, but I’m as happy as I’ve ever been in my life.”It may seem odd that a person could be happy as the end draws near, but in my experience as a clinical psyc

https://www.lucc.lu.se/article/why-are-some-people-happy-when-they-are-dying - 2025-12-13

Since his graduation from the master’s programme in Management in 2018, alumnus Glenn Lio has been on quite the adventure, from military training in Taiwan to rubbing elbows with business leaders in chambers of commerce. Personal reflection, the vivid student life and the importance of community are Glenn’s key learnings from his LUSEM days and experiences he still finds great use for in his job a

https://www.lusem.lu.se/article/glenn-lio-alumnus-msc-management-2018 - 2025-12-14

https://www.lusem.lu.se/article/felix-danielsson-alumnus-bsc-economy-and-society-2023 - 2025-12-14

https://www.lusem.lu.se/article/sofie-bjerling-alumna-msc-international-strategic-management-2019 - 2025-12-14

https://www.lusem.lu.se/article/lusem-leads-swedish-scholarly-delegation-china - 2025-12-14

Art and culture help us to understand society and ourselves. Lund University, with its artistic and cultural knowledge formation, has a key role to play in this. A new Cultural Council has now been formed to act both as a forum for ideas and a discussion partner in this work. “There are entirely new, fresh eyes that see our cultural richness, that see opportunities and connections associated with

https://www.lunduniversity.lu.se/article/new-cultural-council-stimulates-cultural-dialogue - 2025-12-14

One in three patients is asked about their lifestyle habits when they visit the outpatient healthcare clinics. This figure really ought to be higher, according to Professors Hanne Tønnesen and Inger Kristensson Hallström, who are in charge of the WHO Collaborating Centre at Lund University. Lifestyle should concern the health care system even more than it does today,stresses Hanne Tønnesen: “We qu

https://www.medicine.lu.se/article/who-mission-creating-evidence-how-health-care-can-prevent-disease - 2025-12-13

Johan Flygare, Coordinator of the Swedish National ATMP Research School talks about ATMP, about the school and explains why you should apply. Deadline: 15 February. –  ATMP is personally very important to me. Since I started as Deputy Coordinator of the Stem Cell Center, a specific task I have focused on is to make sure our research findings have the best possible chances to reach patients. A part

https://www.intramed.lu.se/en/article/call-applications-swedish-national-atmp-research-school - 2025-12-13

Higher dose cohort initiated after positive early safety evaluation in Parkinson's therapy. After a positive initial safety evaluation, the pioneering STEM-PD clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing a new investigational therapy for Parkinson’s disease aimed at replacing the dopamine cells lost to the disease with healthy ones derived

https://www.multipark.lu.se/article/update-stem-pd-clinical-trial-stem-cell-based-transplant-parkinsons-disease - 2025-12-13

Higher dose cohort initiated after positive early safety evaluation in Parkinson's therapy. After a positive initial safety evaluation, the pioneering STEM-PD clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing a new investigational therapy for Parkinson’s disease aimed at replacing the dopamine cells lost to the disease with healthy ones derived

https://www.medicine.lu.se/article/update-on-stem-pd-clinical-trial-stem-cell-based-transplant-parkinsons-disease - 2025-12-13

In an infection, there are tens of thousands of peptides that provide a wealth of information about which bacteria have caused the infection and how severe it is. A research team at Lund University has now combined clinical questions with mathematical methods to systematically analyze these peptides. This scientific breakthrough has the potential to transform the diagnosis and treatment of infecti

https://www.medicine.lu.se/article/faster-detection-dangerous-infections - 2025-12-13

It has previously been difficult to identify DNA mutations in sperm, as these changes are rare, and most sequencing techniques have a large margin of error. Now a research study led from Lund University, have conducted a pilot study in which they examined sperm DNA and it’s similarity to mutations in children, using the advanced technique called duplex sequencing. Nearly 80 percent of all new muta

https://www.medicine.lu.se/article/new-method-enables-identification-mutations-sperm - 2025-12-13

Obesity is a common cause of diabetes, heart disease and early death, but risk differs greatly from one person to the next. In work led by researchers at Lund University in Sweden as part of the Innovative Medicine Initiative project SOPHIA, a pioneering clinical risk prediction algorithm has been developed that splits obesity into 5 separate diagnostic profiles each with contrasting health conseq

https://www.medicine.lu.se/article/new-precision-medicine-approach-helps-detect-subgroups-people-obesity-high-risk-diabetes-and-heart - 2025-12-13

New research results now published from Lund University’s MASAI trial are even better than the initial findings from last year: AI-supported breast screening detected 29 per cent more cases of cancer compared with traditional screening. More invasive cancers were also clearly detected at an early stage using AI. Now the final part of the research study will focus on breast cancer missed by screeni

https://www.medicine.lu.se/article/ai-supported-breast-cancer-screening-new-results-suggest-even-higher-accuracy - 2025-12-13

Have you noticed that when scientists are asked whether or not a particular extreme weather event is due to climate change, they usually respond with something like "It fits the pattern, but we can't say for sure that this particular event is worse because of climate change"? Weather attribution is a new phenomenon that is changing this. Climate scientist Wilhelm May at Lund University helps us ge

https://www.merge.lu.se/article/weather-attribution-climate-scientist-wilhelm-may-helps-us-get-grips-concept - 2025-12-13

Jan de Boer is a biologist at the department of Biomedical Engineering, Eindhoven University of Technology in The Netherlands. His research interest is in the molecular complexity of cells and how molecular circuits are involved in cell and tissue function. His research is characterized by a holistic approach to both discovery and application, aiming at combining high throughput technologies, comp

https://www.pi.lu.se/en/article/meet-our-new-guest-researcher-jan-de-boer - 2025-12-13

https://www.lusem.lu.se/article/siqi-zhao-alumna-two-lusem-masters-degrees - 2025-12-14

Bringing together experts from diverse fields across the university along with a number of guest researchers, the Pufendorf theme "DigiJustice: Rethinking Digital Inequalities and Human Rights in the Age of AI" will showcase an interdisciplinary approach to digital justice and shaping an inclusive future. Co-led by Miranda Kajtazi, Associate professor in informatics, and Lena Halldenius, Professor

https://www.lusem.lu.se/article/digijustice-interdisciplinary-approach-digital-equality - 2025-12-14

Higher dose cohort initiated after positive early safety evaluation in Parkinson's therapy. After a positive initial safety evaluation, the pioneering STEM-PD clinical trial has advanced to higher dose testing. STEM-PD is a first-in-human clinical trial testing a new investigational therapy for Parkinson’s disease aimed at replacing the dopamine cells lost to the disease with healthy ones derived

https://www.stemcellcenter.lu.se/article/update-stem-pd-clinical-trial-stem-cell-based-transplant-parkinsons-disease - 2025-12-13